Remove Atrial Fibrillation Remove Atrial Flutter Remove COVID-19
article thumbnail

PO-03-070 RISK OF THROMBOEMBOLISM AFTER COVID-19 VACCINATION IN PATIENTS WITH ATRIAL FIBRILLATION/ATRIAL FLUTTER: A SELF-CONTROLLED CASE-SERIES STUDY

HeartRhythm

Concerns about the safety of coronavirus disease (COVID-19) vaccines in patients with atrial fibrillation/atrial flutter (AF/AFL) have arisen due to reports of an association between thromboembolic events and COVID-19 vaccination.

article thumbnail

Prospective arrhythmia surveillance after a COVID-19 diagnosis

Open Heart

Background Cardiac arrhythmias have been observed among patients hospitalised with acute COVID-19 infection, and palpitations remain a common symptom among the much larger outpatient population of COVID-19 survivors in the convalescent stage of the disease. Median monitoring duration was 13.2 (IQR

article thumbnail

Digitally enabled acute care for atrial fibrillation: conception, feasibility and early outcomes of an AF virtual ward

Open Heart

Background Atrial fibrillation (AF) represents a growing healthcare challenge, mainly driven by acute hospitalisations. Methods An AF virtual ward was implemented as a proof-of-concept care model. Methods An AF virtual ward was implemented as a proof-of-concept care model.